Sulindac Increases the Expression of APC MRNA in Malignant Colonic Epithelial Cells: an in Vitro Study

Overview

Journal Gut

Specialty Gastroenterology

Date 1996 May 1

PMID 8707116

Citations 4

Authors

M Schnitzler

T Dwight

B G Robinson

Affiliations

Soon will be listed here.

Abstract

Background: Sulindac is a non-steroidal anti-inflammatory drug which induces regression of colonic polyps in patients with familial adenomatous polyposis. Animal and in vitro studies have shown that both the sulphide metabolite of sulindac, which is able to inhibit cyclo-oxygenase, and the sulphone metabolite, which lacks this ability, are able to inhibit the growth of colonic carcinoma cells. The exact mechanism by which these effects occurs is not known.

Aims: To examine the effect of sulindac sulphide and sulindac sulphone on the expression of APC messenger RNA (mRNA), and on the proliferation of colonic carcinoma cells in vitro.

Methods: The colonic carcinoma cell line LIM 1215 was treated with sulindac sulphide and sulindac sulphone (10 microM or 100 microM) for 24 hours. Total RNA was extracted and APC mRNA was quantitated using competitive reverse transcription polymerase chain reaction. Measurements of cell number, cell proliferation, and prostaglandin E2 concentrations were also made.

Results: A significant increase in APC mRNA was observed after treatment with 10 microM of both sulindac sulphide and sulindac sulphone (control: 37.2 (19.7); 10 microM sulindac sulphide: 129 (112.8); 10 microM sulindac sulphone: 207.7 (102.9) pg/(g total RNA) (p < 0.05). Prostaglandin E2 concentrations were significantly reduced after treatment with sulindac sulphide, but not after sulindac sulphone. Both agents produced a dose dependent reduction in cell numbers and cell proliferation, which was more noticeable after treatment with sulindac sulphide.

Conclusions: Both sulindac sulphide and sulindac sulphone inhibit the growth of carcinoma cells in vitro and cause an increase in APC mRNA. The effect of these agents on colonic carcinogenesis is not mediated entirely by means of an inhibition of prostaglandin biosynthesis.

Citing Articles

Phosphosulindac (OXT-328) selectively targets breast cancer stem cells in vitro and in human breast cancer xenografts.

Zhu C, Cheng K, Ouyang N, Huang L, Sun Y, Constantinides P Stem Cells. 2012; 30(10):2065-75.

PMID: 22653497 PMC: 3621090. DOI: 10.1002/stem.1139.

Sulindac and a cyclooxygenase-2 inhibitor, etodolac, increase APC mRNA in the colon of rats treated with azoxymethane.

Kishimoto Y, Takata N, JINNAI T, Morisawa T, Shiota G, Kawasaki H Gut. 2000; 47(6):812-9.

PMID: 11076880 PMC: 1728141. DOI: 10.1136/gut.47.6.812.

Mutations of adenomatous polyposis coli (APC) gene are uncommon in sporadic desmoid tumours.

Giarola M, Wells D, MONDINI P, Pilotti S, Sala P, Azzarelli A Br J Cancer. 1998; 78(5):582-7.

PMID: 9744495 PMC: 2063069. DOI: 10.1038/bjc.1998.544.

Colon cancer: polyps, prevention, and politics.

Eastwood G Trans Am Clin Climatol Assoc. 1998; 109:107-26; discussion 126-8.

PMID: 9601132 PMC: 2194338.

References

HUCKER H, Stauffer S, White S, Rhodes R, ARISON B, Umbenhauer E . Physiologic disposition and metabolic fate of a new anti-inflammatory agent, cis-5-fluro-2-methyl-1-(p-(methylsulfinyl)-benzylidenyl)-indene-3-acetic acid in the rat, dog, rhesus monkey, and man. Drug Metab Dispos. 1973; 1(6):721-36. View

DUGGAN D, Hooke K, RISLEY E, Shen T, Arman C . Identification of the biologically active form of sulindac. J Pharmacol Exp Ther. 1977; 201(1):8-13. View

Bennett A, Tacca M, Stamford I, ZEBRO T . Prostaglandins from tumours of human large bowel. Br J Cancer. 1977; 35(6):881-4. PMC: 2025548. DOI: 10.1038/bjc.1977.132. View

Knapp H, Oelz O, Sweetman B, OATES J . Synthesis and metabolism of prostaglandins E2, F2alpha and D2 by the rat gastrointestinal tract. Stimulation by a hypertonic environment in vitro. Prostaglandins. 1978; 15(5):751-7. DOI: 10.1016/0090-6980(78)90141-7. View

Verma A, Ashendel C, Boutwell R . Inhibition by prostaglandin synthesis inhibitors of the induction of epidermal ornithine decarboxylase activity, the accumulation of prostaglandins, and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 1980; 40(2):308-15. View

Pollard M, Luckert P . Effect of indomethacin on intestinal tumors induced in rats by the acetate derivative of dimethylnitrosamine. Science. 1981; 214(4520):558-9. DOI: 10.1126/science.7291992. View

Waddell W, Loughry R . Sulindac for polyposis of the colon. J Surg Oncol. 1983; 24(1):83-7. DOI: 10.1002/jso.2930240119. View

Narisawa T, Hermanek P, Habs M, Schmahl D . Reduction of carcinogenicity of N-nitrosomethylurea by indomethacin and failure of resuming effect of prostaglandin E2 (PGE2) against indomethacin. J Cancer Res Clin Oncol. 1984; 108(2):239-42. DOI: 10.1007/BF00402475. View

Whitehead R, Macrae F, St John D, Ma J . A colon cancer cell line (LIM1215) derived from a patient with inherited nonpolyposis colorectal cancer. J Natl Cancer Inst. 1985; 74(4):759-65. View

10.

Chomczynski P, Sacchi N . Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987; 162(1):156-9. DOI: 10.1006/abio.1987.9999. View

11.

Bodmer W, Bailey C, Bodmer J, Bussey H, Ellis A, Gorman P . Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature. 1987; 328(6131):614-6. DOI: 10.1038/328614a0. View

12.

Craven P, Thornburg K, Derubertis F . Sustained increase in the proliferation of rat colonic mucosa during chronic treatment with aspirin. Gastroenterology. 1988; 94(3):567-75. DOI: 10.1016/0016-5085(88)90225-9. View

13.

Hubbard W, Alley M, McLemore T, Boyd M . Profiles of prostaglandin biosynthesis in sixteen established cell lines derived from human lung, colon, prostate, and ovarian tumors. Cancer Res. 1988; 48(17):4770-5. View

14.

Waddell W, Ganser G, CERISE E, Loughry R . Sulindac for polyposis of the colon. Am J Surg. 1989; 157(1):175-9. DOI: 10.1016/0002-9610(89)90442-x. View

15.

Labayle D, Fischer D, Vielh P, Drouhin F, Pariente A, Bories C . Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology. 1991; 101(3):635-9. DOI: 10.1016/0016-5085(91)90519-q. View

16.

Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H . Identification and characterization of the familial adenomatous polyposis coli gene. Cell. 1991; 66(3):589-600. DOI: 10.1016/0092-8674(81)90021-0. View

17.

Kinzler K, Nilbert M, Su L, Vogelstein B, Bryan T, Levy D . Identification of FAP locus genes from chromosome 5q21. Science. 1991; 253(5020):661-5. DOI: 10.1126/science.1651562. View

18.

Rigau J, Pique J, Rubio E, Planas R, Tarrech J, Bordas J . Effects of long-term sulindac therapy on colonic polyposis. Ann Intern Med. 1991; 115(12):952-4. DOI: 10.7326/0003-4819-115-12-952. View

19.

Lim S, Sigmund C, Gross K, Maquat L . Nonsense codons in human beta-globin mRNA result in the production of mRNA degradation products. Mol Cell Biol. 1992; 12(3):1149-61. PMC: 369546. DOI: 10.1128/mcb.12.3.1149-1161.1992. View

20.

Craven P, Derubertis F . Effects of aspirin on 1,2-dimethylhydrazine-induced colonic carcinogenesis. Carcinogenesis. 1992; 13(4):541-6. DOI: 10.1093/carcin/13.4.541. View